Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanoma

Andrea Di Pietro

Lewis Au

Patrick Crock

Niko Thio

Angela Pizzolla

Thu Ngoc Nguyen

Sean Macdonald

Hugh Chalmers

Ruiqing Zhu

Alessia Airaghi

Tristan Molden-Hauer

Marina Bacac

Petra Schwalie

Ramona Schlenker

Mitchell P. Levesque

Sonia Mailer

Kristy Barnes-Cullen

Karen Winch

Joanna Chan

George Au Yeung

Lavinia Spain

Aparna D. Rao

Shahneen Sandhu

From the Sandra and Edward Meyer Cancer Center (J.D.W.) and the Department of Medicine (J.D.W., M.A.P.), Weill Cornell Medicine, and Memorial Sloan Kettering Cancer Center (M.A.P.) — both in New York; Istituto Oncologico Veneto, IRCCS, Padua (V.C.-S.), European Institute of Oncology, IRCCS, Milan (P.Q.), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola (M.G.), University of Siena and the Center for Immuno-Oncology, University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples (P.A.A.) — all in Italy; Maria Sklodowska-Curie National Institute of Oncology, Warsaw, Poland (P.R.); Texas Oncology–Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); University Hospital Essen, the German Cancer Consortium, the National Center for Tumor Diseases–West, the Research Alliance Ruhr, Research Center One Health, and University Duisburg-Essen — all in Essen, Germany (D.S.); the College of Medicine, Swansea University, Swansea (J.W.), Brist...

David E. Gyorki

Grant A. McArthur

Laura K. Mackay

Paul J. Neeson